发明名称 CHOLESTEROL EFFLUX CAPACITY ASSESSMENT
摘要 A method is provided for transforming one or more biomarkers into a cholesterol efflux capacity (CEC) value. Methods relate to determining SR-BI-mediated and ABCA1-mediated CEC. CEC may be used for compound screening and to determine risk of cardiovascular disease and to recommend or administer treatment regimens.
申请公布号 US2016327579(A1) 申请公布日期 2016.11.10
申请号 US201514744729 申请日期 2015.06.19
申请人 Boston Heart Diagnostics 发明人 Asztalos Bela F.;Riel-mehan Michael;Schaefer Ernst J.
分类号 G01N33/92;G06F19/00 主分类号 G01N33/92
代理机构 代理人
主权项 1. A method for determining an ABCA1-mediated cholesterol efflux capacity (CEC) of an individual comprising: obtaining a sample from an individual; measuring a triglyceride level in the sample; receiving the triglyceride level at a computing device comprising a tangible, non-transient memory coupled to a processor; transforming the triglyceride level into an ABCA1-mediated CEC value for the individual through the application, by the processor, of a predetermined rule, wherein the predetermined rule is stored in the tangible, non-transient memory; and creating a written report comprising the ABCA1-mediated CEC value for the individual.
地址 Framingham MA US